-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

Benzinga·04/23/2026 17:42:11
Listen to the news
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $100 to $95.